IMP321 as Adjunctive to a Standard Chemotherapy ...
https://www.clinicaltrials.gov/ct2/show/NCT02614833
Nov 5, 2015 - Last updated: February 19, 2016 ... Assessment of the safety and tolerability of IMP321 as compared to placebo (adverse events and serious ...
- Forums
- ASX - By Stock
- Ann: Prima unveils Phase I combination study of IMP321
IMP321 as Adjunctive to a Standard Chemotherapy ......
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
40.8¢ |
Change
0.013(3.16%) |
Mkt cap ! $588.3M |
Open | High | Low | Value | Volume |
38.5¢ | 41.0¢ | 38.5¢ | $814.0K | 2.043M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 35235 | 40.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
41.0¢ | 325820 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 124852 | 0.400 |
15 | 97094 | 0.395 |
11 | 96876 | 0.390 |
12 | 136104 | 0.385 |
13 | 140060 | 0.380 |
Price($) | Vol. | No. |
---|---|---|
0.405 | 21549 | 7 |
0.410 | 364620 | 13 |
0.415 | 283172 | 13 |
0.420 | 535406 | 13 |
0.425 | 103692 | 7 |
Last trade - 11.34am 03/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |